Ignite Creation Date:
2025-12-24 @ 12:14 PM
Ignite Modification Date:
2026-01-21 @ 11:39 PM
Study NCT ID:
NCT02921061
Status:
COMPLETED
Last Update Posted:
2020-03-17
First Post:
2016-09-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
Sponsor:
Fred Hutchinson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Mixed Phenotype Acute Leukemia | View |
| None | Previously Treated Myelodysplastic Syndrome | View |
| None | Recurrent Adult Acute Myeloid Leukemia | View |
| None | Recurrent High Risk Myelodysplastic Syndrome | View |
| None | Refractory Acute Myeloid Leukemia | View |
| None | Refractory High Risk Myelodysplastic Syndrome | View |
| None | Untreated Adult Acute Myeloid Leukemia | View |
Keywords: